These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages. Jiang C; Yuan F; Wang J; Wu L Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495 [TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008 [TBL] [Abstract][Full Text] [Related]
51. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast. Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685 [TBL] [Abstract][Full Text] [Related]
52. M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer. Cao L; Che X; Qiu X; Li Z; Yang B; Wang S; Hou K; Fan Y; Qu X; Liu Y Cancer Manag Res; 2019; 11():6125-6138. PubMed ID: 31308749 [No Abstract] [Full Text] [Related]
53. Expression of CD68 and CD163 in malignant epithelial cells of oral squamous cell carcinoma: Phenotypic shift or mere cell fusion. Essa AAM; Korayem MAM; Alghamdi MA; Alzahrani RA; Malibari NM; Kandil HE Pathol Res Pract; 2024 Nov; 263():155639. PubMed ID: 39383735 [TBL] [Abstract][Full Text] [Related]
54. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. Yagi T; Baba Y; Okadome K; Kiyozumi Y; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H Eur J Cancer; 2019 Apr; 111():38-49. PubMed ID: 30822683 [TBL] [Abstract][Full Text] [Related]
55. High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma. Svensson MC; Svensson M; Nodin B; Borg D; Hedner C; Hjalmarsson C; Leandersson K; Jirström K J Innate Immun; 2022; 14(6):615-628. PubMed ID: 35504250 [TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas. Weber M; Iliopoulos C; Moebius P; Büttner-Herold M; Amann K; Ries J; Preidl R; Neukam FW; Wehrhan F Oral Oncol; 2016 Jan; 52():75-84. PubMed ID: 26728105 [TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma. Minami K; Hiwatashi K; Ueno S; Sakoda M; Iino S; Okumura H; Hashiguchi M; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S Exp Ther Med; 2018 May; 15(5):4465-4476. PubMed ID: 29731831 [TBL] [Abstract][Full Text] [Related]
58. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818 [TBL] [Abstract][Full Text] [Related]
59. High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis. Li P; Yuan J; Ahmed FS; McHenry A; Fu K; Yu G; Cheng H; Xu ML; Rimm DL; Pan Z Front Oncol; 2021; 11():701492. PubMed ID: 34527580 [TBL] [Abstract][Full Text] [Related]